Gilead Sciences GILD Business Segments — Selling, general and administrative expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gilead Sciences's business segments — selling, general and administrative expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Gilead Sciences's business segments — selling, general and administrative expenses?
- Gilead Sciences (GILD) reported business segments — selling, general and administrative expenses of $1.45B in Q1 2026.
- How has Gilead Sciences's business segments — selling, general and administrative expenses changed year-over-year?
- Gilead Sciences's business segments — selling, general and administrative expenses increased by 15.3% year-over-year, from $1.26B to $1.45B.
- What is the long-term trend for Gilead Sciences's business segments — selling, general and administrative expenses?
- Over 3 years (2022 to 2025), Gilead Sciences's business segments — selling, general and administrative expenses has grown at a 0.6% compound annual growth rate (CAGR), from $5.67B to $5.77B.
- What does business segments — selling, general and administrative expenses mean?
- This metric represents the aggregate of all selling, marketing, and general administrative expenses required to support the company's operations. It serves as a primary measure of the non-production operating costs necessary to sustain the business and drive revenue. Investors use this to evaluate the company's overall operating leverage and cost discipline.